The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis

IMPORTANCE: A number of officially approved disease-modifying drugs (DMD) are currently available for the early intervention in patients with relapsing-remitting multiple sclerosis (RRMS). The aim of the present study was to systematically evaluate the effect of DMDs on disability progression in RRM...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsivgoulis, Georgios, Katsanos, Aristeidis H., Grigoriadis, Nikolaos, Hadjigeorgiou, Georgios M., Heliopoulos, Ioannis, Papathanasopoulos, Panagiotis, Kilidireas, Constantinos, Voumvourakis, Konstantinos, Dardiotis, Efthimios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671570/
https://www.ncbi.nlm.nih.gov/pubmed/26642051
http://dx.doi.org/10.1371/journal.pone.0144538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671570/
https://www.ncbi.nlm.nih.gov/pubmed/26642051
http://dx.doi.org/10.1371/journal.pone.0144538

Ejemplares similares